Xanthakos Stavra, Miles Lili, Bucuvalas John, Daniels Stephen, Garcia Victor, Inge Thomas
Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Clin Gastroenterol Hepatol. 2006 Feb;4(2):226-32. doi: 10.1016/s1542-3565(05)00978-x.
BACKGROUND & AIMS: To characterize the spectrum of nonalcoholic fatty liver disease (NAFLD) in morbidly obese adolescents, we correlated liver histology with clinical features and compared findings with reported adult data. We hypothesized that NAFLD would be less severe as a result of younger age and shorter duration of obesity, but portal inflammation and fibrosis would be more prevalent.
Cross-sectional study was made of 41 adolescent subjects, 13-19 years old (mean, 16 years), 61% female, 83% non-Hispanic white, mean body mass index 59 kg/m(2), undergoing gastric bypass with liver biopsy. Liver biopsies were graded and staged as proposed by the NASH Clinical Research Network. Data were analyzed by using descriptive statistics, analysis of variance, and Fisher exact tests.
Eighty-three percent had NAFLD: 24% steatosis alone, 7% isolated fibrosis with steatosis, 32% nonspecific inflammation and steatosis, and 20% nonalcoholic steatohepatitis (NASH). Twenty-nine percent had fibrosis; none had cirrhosis. Abnormal ALT (P = .05) and AST (P = .01) were more prevalent in NASH. Mean fasting glucose was significantly higher in NASH (P = .05), but prevalence of the metabolic syndrome was not significantly different.
NAFLD was very prevalent in morbidly obese adolescents, but severe NASH was uncommon. In contrast to morbidly obese adults, lobular inflammation, significant ballooning, and perisinusoidal fibrosis were rare, whereas portal inflammation and portal fibrosis were more prevalent, even in those who did not meet criteria for NASH. These findings might support use of a modified scoring system for pediatric NASH. Presence of the metabolic syndrome in morbidly obese adolescents did not distinguish NASH from steatosis alone.
为了明确病态肥胖青少年非酒精性脂肪性肝病(NAFLD)的情况,我们将肝脏组织学与临床特征进行了关联,并将结果与已报道的成人数据进行了比较。我们推测,由于年龄较小且肥胖持续时间较短,NAFLD的病情会较轻,但门脉炎症和纤维化会更普遍。
对41名13 - 19岁(平均16岁)的青少年受试者进行了横断面研究,其中61%为女性,83%为非西班牙裔白人,平均体重指数为59kg/m²,这些受试者在接受胃旁路手术时进行了肝脏活检。肝脏活检按照非酒精性脂肪性肝炎(NASH)临床研究网络的提议进行分级和分期。数据采用描述性统计、方差分析和Fisher精确检验进行分析。
83%的受试者患有NAFLD:仅脂肪变性占24%,脂肪变性伴孤立性纤维化占7%,非特异性炎症伴脂肪变性占32%,非酒精性脂肪性肝炎(NASH)占20%。29%的受试者有纤维化;无人有肝硬化。NASH患者中异常丙氨酸氨基转移酶(ALT)(P = 0.05)和天冬氨酸氨基转移酶(AST)(P = 0.01)更为普遍。NASH患者的平均空腹血糖显著更高(P = 0.05),但代谢综合征的患病率无显著差异。
NAFLD在病态肥胖青少年中非常普遍,但严重的NASH并不常见。与病态肥胖成人不同,小叶炎症、显著气球样变和窦周纤维化很少见,而门脉炎症和门脉纤维化更普遍,即使在那些不符合NASH标准的患者中也是如此。这些发现可能支持对儿童NASH采用改良的评分系统。病态肥胖青少年中代谢综合征的存在并不能区分NASH与单纯脂肪变性。